2,900 Shares in Astera Labs, Inc. $ALAB Acquired by B. Metzler seel. Sohn & Co. AG

B. Metzler seel. Sohn & Co. AG bought a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 2,900 shares of the company’s stock, valued at approximately $482,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Assetmark Inc. raised its holdings in Astera Labs by 374.1% during the third quarter. Assetmark Inc. now owns 128 shares of the company’s stock worth $25,000 after purchasing an additional 101 shares in the last quarter. Wexford Capital LP bought a new stake in Astera Labs during the third quarter worth approximately $39,000. Hilltop National Bank raised its holdings in Astera Labs by 100.0% during the fourth quarter. Hilltop National Bank now owns 200 shares of the company’s stock worth $33,000 after purchasing an additional 100 shares in the last quarter. Aventura Private Wealth LLC bought a new stake in Astera Labs during the fourth quarter worth approximately $33,000. Finally, National Bank of Canada FI raised its holdings in Astera Labs by 159.0% during the third quarter. National Bank of Canada FI now owns 202 shares of the company’s stock worth $39,000 after purchasing an additional 124 shares in the last quarter. Institutional investors own 60.47% of the company’s stock.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, Director Manuel Alba sold 183,000 shares of the business’s stock in a transaction on Wednesday, April 1st. The shares were sold at an average price of $107.61, for a total transaction of $19,692,630.00. Following the completion of the transaction, the director owned 319,863 shares of the company’s stock, valued at $34,420,457.43. The trade was a 36.39% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 3,757 shares of the business’s stock in a transaction on Monday, April 20th. The stock was sold at an average price of $175.12, for a total transaction of $657,925.84. Following the transaction, the director directly owned 67,144 shares of the company’s stock, valued at approximately $11,758,257.28. This represents a 5.30% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 1,064,888 shares of company stock valued at $150,764,723. Company insiders own 12.50% of the company’s stock.

Astera Labs Stock Down 7.6%

Astera Labs stock opened at $196.64 on Tuesday. The company’s fifty day simple moving average is $135.22 and its 200-day simple moving average is $152.95. Astera Labs, Inc. has a 12 month low of $62.31 and a 12 month high of $262.90. The stock has a market cap of $33.68 billion, a P/E ratio of 161.18, a P/E/G ratio of 4.19 and a beta of 1.78.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, topping the consensus estimate of $0.51 by $0.07. The company had revenue of $270.58 million during the quarter, compared to the consensus estimate of $249.46 million. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The company’s revenue for the quarter was up 91.8% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.37 earnings per share. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. On average, equities research analysts expect that Astera Labs, Inc. will post 1.48 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

ALAB has been the topic of several research reports. Weiss Ratings cut Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a report on Monday, February 23rd. Citigroup initiated coverage on Astera Labs in a report on Thursday, April 2nd. They issued a “buy” rating and a $200.00 price target on the stock. Loop Capital initiated coverage on Astera Labs in a report on Thursday, March 5th. They issued a “buy” rating and a $250.00 price target on the stock. UBS Group initiated coverage on Astera Labs in a report on Tuesday, April 21st. They issued a “neutral” rating and a $180.00 price target on the stock. Finally, Barclays set a $165.00 price target on Astera Labs in a report on Thursday, January 15th. Fifteen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Astera Labs currently has a consensus rating of “Moderate Buy” and a consensus price target of $199.74.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.